Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-110

Question for you.

The prelim results did meet primary objectives. Without knowledge of the final results and only going by the prelim results, it is fair to say that the results did not EXCEED primary objectives.

Under those circumstances, why do you think there is any possibility at all of any TO offer being in the pipeline?

Normally, a TO would come with exceptional results and that would be in PH3 trials as a general rule of thumb.

Without that possibility, then a realistic and grounded approach would be to look at what comes next - and talk of a CR is discussing the next valid step. Not sure why you would want to denigrate that logical and current situation it is real life discussion. Limiting conversations to just hope. dreams and blind faith based on no firm evidence seems to be counterintuitive at best.

Be very interested in your comments.